|
Sign In to gain access to subscriptions and/or personal tools.
|
Osteonecrosis of the Jaws and Bisphosphonate Therapy
S.L. Ruggiero1,2,* and
S.J. Drew2
1 Department of Oral and Maxillofacial Surgery, Stony Brook School of Dental Medicine, Long Island Jewish Medical Center, Division of Oral and Maxillofacial Surgery, New Hyde Park, NY; and
2 New York Center for Orthognathic and Maxillofacial Surgery, 2001 Marcus Ave., Suite N10, Lake Success, NY 11042, USA

View larger version (97K):
[in this window]
[in a new window]
|
Figure 1. Clinical and radiographic appearance of osteonecrosis of the jaws. (A) Non-healing extraction site in a patient with breast cancer and a history of zolendronic acid exposure. (B) Spontaneous necrosis of the right posterior maxillary alveolus in a patient with prostate cancer and a history of pamidronate exposure. (C) Extra-oral draining fistula in a patient with Stage 3 BRONJ. (D) Extensive necrosis of the anterior mandible in a patient with a history of metastatic breast cancer and long-term zolendronic acid exposure (Stage 3 BRONJ). (E) Axial CT scan of the mandible osteolysis of the left mandible with sequestrum formation in a multiple myeloma patient. (F) Panoramic radiograph demonstrating a pathologic fracture and osteolysis of the left mandible (Stage 3 BRONJ) in a patient exposed to long-term pamidronate therapy.
|
|
Journal of Dental Research, Vol. 86, No. 11,
1013-1021 (2007)
DOI: 10.1177/154405910708601101

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|